CanSino Biologics Archives -

Pierre A. Morgon, PharmD, LL.M, MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single

CanSinoBIO developed a highly effective COVID vaccine with an inhalant version

https://pharmaphorum.com/r-d/cansinobio-developed-highly-effective-covid-vaccine-with-inhalant-version/

Early-stage clinical data with CanSino Biologics’ inhaled COVID-19 vaccine show that it was able to stimulate neutralising antibodies

First published data backs CanSino’s inhaled COVID vaccine

https://pharmaphorum.com/news/first-published-data-backs-cansinos-inhaled-covid-vaccine/

Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but

Losing ground in COVID-19 vaccine race, CanSino turns to Russia

https://pharmaphorum.com/news/losing-ground-in-covid-19-vaccine-race-cansino-turns-to-russia/

Data from more than 1,000 healthy volunteers dosed with a coronavirus vaccine developed at Oxford University and AstraZeneca

‘Promising’ data on Oxford/AZ, CanSino coronavirus vaccines

https://pharmaphorum.com/news/first-data-on-oxford-astrazeneca-cansino-coronavirus-vaccines-promising/

US-based Inovio has become the third biotech to begin clinical development of a vaccine against the COVID-19 coronavirus.

Inovio begins clinical trial of COVID-19 vaccine

https://pharmaphorum.com/news/inovio-begins-clinical-trial-of-covid-19-vaccine/

CanSino Biologics